Cataract Surgery News

While there are currently no FDA-approved pharmacological therapies for the treatment of cataracts, an eye drop demonstrated promising vision improvements in patients with early-stage cataracts in a phase 1/2 clinical trial.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Jorge L. Alió, MD, PhD, speaks about the physical principles of extended depth of focus lenses.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Francesco Carones, MD, shares his clinical experience with the Tecnis PureSee IOL.

BARCELONA, Spain — In this Healio Video Perspective from Presbyopia 2024, held before the European Society of Cataract and Refractive Surgeons meeting, Fritz Hengerer, MD, PhD, discusses the OmniVu modular shape-changing IOL.

With cataract surgery, our primary goal is simple: to improve visual quality by eliminating the symptoms of poor contrast, blurred vision and glare from the cataract.

Many patients desire a refractive correction at the same time as cataract surgery. This makes sense because we can correct a large degree of spherical refractive error as well as astigmatism with proper planning.

Hi, I'm Yari, and I have questions. And I'm here with Dr. Kohnen, and he has answers. Let's see if they match. Hi, Dr. Kohnen, thank you for joining me today.

HCP Cureblindness is rebranding as the Cure Blindness Project, according to a press release.

Hi, I'm Yari, and I have questions. And this is Dr. Arjan Hura, and he has answers. Let's see if they match. Hey Arjan, thank you for joining me today.